Mike Henry

Mike Henry is Chief Business Officer at Aldatu Biosciences, the leader in adaptive PCR diagnostics for global health and emerging diseases. Mike is a molecular diagnostics expert with over 20 years of senior leadership experience in biotechnology business development at Ancestry, Quest Diagnostics, Thermo Fisher, Athena Diagnostics and other life science companies, and in medical technology transfer at academic medical centers. He sold Athena to Quest for $740M in 2011. Mike is an advisor with biotech startups and a member of Berkeley Angel Network. Mike has an MBA and an MA from University of California Berkeley and a BS from University of Michigan.